- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06269406
A Combination of Ibuprofen With Curcumin Covered With Liquorice Root Supplementation in the Management of Postoperative Dental Pain in Adults (ICLID)
February 20, 2024 updated by: S.LAB (SOLOWAYS)
A Combination of Ibuprofen With Curcumin Covered With Liquorice Root Supplementation in the Management of Postoperative Dental Pain in Adults, Randomized, Double- Blind, Parallel-Group, Placebo-Controlled Study
Dental pain, a common issue in stomatology, requires a multifaceted treatment approach.
This study explores the efficacy of combining Ibuprofen with curcumin and liquorice root supplements for managing postoperative dental pain.
Curcumin, known for its antioxidant and anti-inflammatory properties, along with liquorice root, may enhance pain relief beyond conventional NSAIDs like Ibuprofen.
This randomized, double-blind, placebo-controlled trial aims to evaluate the safety and effectiveness of this combination therapy in adults undergoing the removal of impacted third molars.
Participants, aged 18-85, were divided into groups receiving different doses of Ibuprofen and curcumin with liquorice root, compared to a control group receiving Ibuprofen and placebo.
The primary outcome is the sum of pain intensity differences over 8 hours, with secondary outcomes including total pain relief and the occurrence of any adverse events.
The anticipated sample size, considering a 20% dropout rate, is 264 participants, ensuring the study is powered to detect significant differences in pain management efficacy.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
264
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Novosibirsk Region
-
Novosibirsk, Novosibirsk Region, Russian Federation, 630090
- Nmsi Dentmaster
-
Contact:
- Gatilova A Tatyana, MD
- Phone Number: +7 9529399919
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Removal of 2 to 4 impacted third molars
Exclusion Criteria:
- Pregnancy or breastfeeding
- Ibuprofen contraindications.
- Allergy to any of the intervention components.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group ibuprofen 400 and Curcumin
|
Dietary supplement: ibuprofen 400 mg in combination with Curcumin covered with liquorice root 100 mg
The combination of ibuprofen 400 mg and Curcumin covered with liquorice root 100 mg in patients after 2-4 molars procedure
|
Experimental: Intervention Group ibuprofen 200 and Curcumin
|
Dietary supplement: ibuprofen 200 mg in combination with Curcumin covered with liquorice root 100 mg
The combination of ibuprofen 200 mg and Curcumin covered with liquorice root 100 mg in patients after 2-4 molars procedure
|
Placebo Comparator: Intervention Group ibuprofen 400 and placebo
|
The combination of ibuprofen 400 mg and placebo 100 mg in patients after 2-4 molars procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sum of pain intensity differences (SPID), SPID on the visual analog score VAS (points)
Time Frame: 8 hours
|
8 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total pain relief (TOTPAR) %
Time Frame: 8 hours
|
8 hours
|
Time to pain half pain gone (in minutes)
Time Frame: 8 hours
|
8 hours
|
Duration of pain half gone (in minutes)
Time Frame: 8 hours
|
8 hours
|
Any adverse events (facial swelling, nausea, vomiting, headache) (%)
Time Frame: 8 hours
|
8 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 10, 2024
Primary Completion (Estimated)
July 10, 2024
Study Completion (Estimated)
September 10, 2024
Study Registration Dates
First Submitted
February 12, 2024
First Submitted That Met QC Criteria
February 20, 2024
First Posted (Estimated)
February 21, 2024
Study Record Updates
Last Update Posted (Estimated)
February 21, 2024
Last Update Submitted That Met QC Criteria
February 20, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Stomatognathic Diseases
- Tooth Diseases
- Facial Pain
- Toothache
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Antineoplastic Agents
- Ibuprofen
- Curcumin
Other Study ID Numbers
- SW008
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Pain
-
Organon and CoCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
GlaxoSmithKlineCompletedPost-surgical Dental PainUnited States
-
Cairo UniversityUnknown
-
Johnson & Johnson Consumer Inc., McNeil Consumer...Johnson & Johnson Consumer and Personal Products WorldwideCompleted
-
Johnson & Johnson Consumer Inc., McNeil Consumer...CompletedPost-operative Dental PainUnited States
-
Novartis PharmaceuticalsCompleted
-
GlaxoSmithKlineCompletedPost-surgical Dental PainUnited States
-
PfizerTerminatedPost-surgical Dental PainUnited States
Clinical Trials on ibuprofen 400 mg in combination with Curcumin covered with liquorice root 100 mg
-
PfizerTerminatedNon-small Cell Lung Cancer | Urothelial CancerSpain, Czechia, United States, Australia, United Kingdom, Italy, Canada, Hungary
-
Sephoris Pharmaceuticals LLCTerminated
-
Assiut UniversityUnknownChronic Myeloid Leukemia Patients
-
Xuanhan County People's HospitalCompletedAnalgesia | Gynecological; Surgery (Previous), Affecting Fetus or Newborn, Due to Obstructed LaborChina
-
RemeGen Co., Ltd.Recruiting
-
Right to CareBoston University; University of California, Los Angeles; Ministry of Health... and other collaboratorsCompletedHIV Infections | Hepatitis B | Hepatitis CMyanmar
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Cyteir Therapeutics, Inc.Active, not recruitingSoft Tissue Sarcoma | Follicular Lymphoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Multiple Myeloma | Pancreatic Cancer | Ovarian Cancer | Mantle Cell Lymphoma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | DLBCL | Non-hodgkin Lymphoma | Malignancy | CLLUnited States
-
Frank LippertThe Borrow FoundationCompleted
-
Cairo UniversityNot yet recruiting